Prosecution Insights
Last updated: October 08, 2026

Saul Ewing LLP (Philadelphia)

Technology area: Biotechnology & Pharmaceuticals

165 pending office actions • 74 clients • 156 examiners • 83 art units • 0 of 165 (0%) have an AI response strategy ready

Analysis

Saul Ewing LLP (Philadelphia) manages 5437 career applications, with a focus on Biotechnology & Pharmaceuticals. The firm has a resolved allowance rate of 81.42 percent. Prosecution in these complex fields is intensive, averaging 3.94 office actions per allowance, which reflects the detailed examination process for life sciences. This average indicates a persistent approach to overcoming the technical and legal hurdles common in biotech.

The firm is currently handling 138 pending office actions. This active workload is part of its 5437 career applications. The 81.42 percent allowance rate indicates a strong ability to secure patents in the biotechnology and pharmaceutical sectors. While 3.94 office actions per allowance suggests a longer and more involved prosecution path, it is typical for the high-stakes and complex nature of the firm's primary technology area. Clients can expect a thorough and dedicated prosecution cycle based on these established metrics.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=5449 apps, methodology: how we score firms)

81.4%
Allowance Rate
n=5449
+0.67σ
Allowance Rate (norm)
n=5449
3.9
OAs to Allowance
n=2490
+0.02σ
OAs to Allow (norm)
n=2490
1114 days
Time to Allowance
n=2490
+17.3pp
Interview Lift
n=5449
31.9%
RCE Rate
n=5449
1.4%
Appeal Rate
n=5449

Rejection Performance (% of received rejections ultimately overcome)

71.8%
§101 Overcome
n=468
73.6%
§102 Overcome
n=1229
75.3%
§103 Overcome
n=2013
77.6%
§112 Overcome
n=1844

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
28%
Top-3 CPC Share
n=5449
0
Practitioners
n=5449
—
Apps / Practitioner
n=5449 (min 20)

Portfolio Summary

165
Total Pending OAs
108
Non-Final OAs
53
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 50 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

27
Overdue
1
Due this week
8
Due this month
8
Due in next 60 days
6
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 50 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (27)Due ≤ 7 days (1)Due ≤ 30 days (8)Due ≤ 60 days (8)Due later (6)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

81
Hard (49%)
63
Medium (38%)
20
Easy (12%)
1
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only4 (2%)
§101 + other18 (11%)
§103 only35 (21%)
§102 only6 (4%)
§112 only17 (10%)
Double-patenting only3 (2%)
Double-patenting + other22 (13%)
Multi-statute (no §101)59 (36%)
No statute on record1 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

95
Life Sciences
58% of docket
7
Information Tech
4% of docket
4
Communications
2% of docket
0
Semiconductors
0% of docket
29
Mechanical / Eng
18% of docket
30
Business / Other
18% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,650 h
Manual time on pending OAs
330 h
Time saved (low, 20%)
578 h
Time saved (mid, 35%)
14.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
YEN, ERIC L 2 85.1% +11.6%
WAGGONER, TIMOTHY R 2 71.6% +7.7%
LEE, CHIHYI NMN 2 33.3% +61.1%
SONG, JIANFENG 2 56.3% +33.2%
GREENE, CAROLYN LEE 2 65.7% +46.1%
AMICK, THOMAS RUSSE 2 73.3% +30.1%
JUEDES, AMY E 2 44.8% +41.8%
SWARTZ, STEPHEN S 2 31.6% +26.2%
CHEN, STACY BROWN 2 66.1% +40.6%
RAZA, ZEHRA 1 45.3% +48.3%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19396998 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL YEN, ERIC L —
19397080 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL YEN, ERIC L —

Hard Cases (81)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18809238 MULTIDAY TIMED ENTRY TICKET SYSTEM FOR RECURRING EVENTS KIM, PATRICK 252d overdue
17771464 SYSTEM INCLUDING A SERVER SYSTEM, A PLURALITY OF GATEWAYS AND A DEVICE NGUYEN, LINH T 111d overdue
18327393 METHOD AND SERVER FOR PROVIDING FARE AVAILABILITIES, SUCH AS AIRFARE AVAILABILITIES SWARTZ, STEPHEN S 93d overdue
17378274 HUMAN MIRNAS FOR USE IN DIAGNOSIS, PROGNOSIS, AND THERAPY OF HUMAN CONDITIONS AND DISEASES DACE DENITO, ALEXANDRA GERALDINE 84d overdue
17222216 METHODS, DEVICES, SYSTEMS AND COMPUTER PROGRAM PRODUCTS WHICH RELATE TO TRAVEL ARRANGEMENTS WALSH, EMMETT K 79d overdue
18631383 ADJUSTABLE INFANT TUB DEERY, ERIN LEAH 38d overdue
17340497 METHOD AND SERVER FOR PROVIDING A SET OF PRICE ESTIMATES, SUCH AS AIR FARE PRICE ESTIMATES SWARTZ, STEPHEN S 36d overdue
18276582 CCR4-Targeting Chimeric Antigen Receptor Cell Therapy EDGINGTONGIORDANO, FRANCESCA 23d overdue

Interview Candidates (17)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18327393 METHOD AND SERVER FOR PROVIDING FARE AVAILABILITIES, SUCH AS AIRFARE AVAILABILITIES SWARTZ, STEPHEN S 93d overdue
17340497 METHOD AND SERVER FOR PROVIDING A SET OF PRICE ESTIMATES, SUCH AS AIR FARE PRICE ESTIMATES SWARTZ, STEPHEN S 36d overdue
18483225 Combination Therapy for Treating or Preventing Depression or Other Mood Diseases LEE, CHIHYI NMN 18d overdue
18004517 ENHANCING IMMUNE RESPONSES THROUGH TARGETED ANTIGEN EXPRESSION CHEN, STACY BROWN 8d
18749726 Combination Therapy for Treating or Preventing Depression or Other Mood Diseases LEE, CHIHYI NMN 34d
18354345 COMPOSITIONS AND METHODS FOR FILTERING MICROORGANISMS FROM A FLUID SONG, JIANFENG 39d
18034720 GENE SHUFFLED LYSSAVIRUS VACCINE CHEN, STACY BROWN 61d
19396998 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL YEN, ERIC L —

Client Portfolio (74 clients)

View all 74 →

Top Art Units

Art UnitApps
16266
16335
16224
36153
36553
16583
16283
37913
16133
16323

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19396998 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED YEN, ERIC L 2658 §112 Non-Final OA — Pending Nov 21, 2025
19397080 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED YEN, ERIC L 2658 §112 Non-Final OA — Pending Nov 21, 2025
19287313 SYSTEMS AND METHODS FOR A PERMISSIONLESS DECENTRALIZED VIRTUAL ASSET NETWORK Pylons, Inc. RAZA, ZEHRA §101§103 Non-Final OA — Pending Jul 31, 2025
19252753 SEALING RINGS John Crane Inc. PATEL, VISHAL A 3675 §102§103§112 Non-Final OA — Pending Jun 27, 2025
19243684 SYSTEM AND METHOD FOR CONTROLLING A SMART GRIPPING APPARATUS Nexera Robotics Corp. JOHNSON, KYLE T 3656 §102§103§112 Non-Final OA — Pending Jun 19, 2025
19198089 DIGITAL WATERMARKING WITHOUT SIGNIFICANT INFORMATION LOSS IN ANONYMIZED DATASETS Privitar Limited AMBAYE, SAMUEL 2431 §103 Non-Final OA — Pending May 04, 2025
19098726 SYSTEM AND METHOD FOR MONITORING A DWELLING Mwc Family LP PENDLETON, DIONNE §102§103 Non-Final OA — Pending Apr 02, 2025
19060987 METHOD AND SYSTEM FOR ANALYSING SOUND X-System Limited ZHU, QIN §103Other Non-Final OA — Pending Feb 24, 2025
19047424 LIFTING DEVICE HAVING A RETRACTABLE FOOT PEDAL TO LIFT PATIENTS TO STANDING POSITION Restorative Care Of America, Inc. HALL, LUKE F 3673 §102§112 Final Rejection 5d Pending Feb 06, 2025
18997039 VIDEO ENCODING AND DECODING BLACKBIRD PLC CHANG, DANIEL 2487 §103 Non-Final OA 45d overdue Pending Jan 18, 2025
19031738 ELECTRONIC VAPING SYSTEM Ayr Ltd. WILL, KATHERINE A 1747 §103 Non-Final OA — Pending Jan 18, 2025
19029666 E-CIGARETTE PERSONAL VAPORIZER Ayr Ltd. YAARY, ERIC 1755 §102§103§112 Non-Final OA — Pending Jan 17, 2025
18878564 NOVEL SARGASSUM-BASED POLYMER COMPOSITE FILAMENTS FOR 3D PRINTING AND METHOD OF MAKING THE SAME Rutgers, The State University Of New Jersey WILLIAMS, CEDRICK S 1749 §112 Final Rejection — Pending Dec 23, 2024
18990832 NON-PNEUMATIC TIRE AND METHOD OF MANUFACTURE THEREOF The Carlstar Group LLC BELLINGER, JASON R 3615 §103§112DP Non-Final OA — Pending Dec 20, 2024
18987814 METHODS OF INCORPORATING SPORADIC OBJECTS ONTO AN EXISTING MESH Yale University SUO, JOSHUA JUNGWOOK §103 Non-Final OA — Pending Dec 19, 2024
18982106 COMPOSITIONS AND METHODS OF USING HisGTG TRANSFER RNAS (tRNAs) Thomas Jefferson University SWITZER, JULIET CAROLINE 1682 §101§102§103§112DP Non-Final OA — Pending Dec 16, 2024
18972744 TOTE MANIPULATOR MECHANISM Locus Robotics Corp. WAGGONER, TIMOTHY R 3655 §102Other Non-Final OA — Pending Dec 06, 2024
18972706 AN AUTONOMOUS MOBILE ROBOT WITH A TOTE MAGAZINE AND A TOTE ELEVATOR Locus Robotics Corp. WAGGONER, TIMOTHY R 3655 §102§103 Final Rejection — Pending Dec 06, 2024
18972728 PRE-QUEUEING OF ORDER TOTES Locus Robotics Corp. HOLMES, JUSTIN 3655 §103Other Non-Final OA — Pending Dec 06, 2024
18967105 LASER-INDUCED CARBON NANOSTRUCTURES Integrated Graphene Holding Limited AMEEN, MOHAMMAD M 1742 DP Final Rejection — Pending Dec 03, 2024
18935127 ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME BAUSCH HEALTH IRELAND LIMITED PATEL, RONAK C 1658 §102DPOther Non-Final OA — Pending Nov 01, 2024
18856855 BIODEGRADABLE LIPIDOIDS AND COMPOSITIONS AND METHODS OF USE THEREOF FOR TARGETED DELIVERY The Trustees of the University of Pennsylvania DAVIS, BRIAN J §102§112 Non-Final OA — Pending Oct 14, 2024
18853928 SYSTEMS AND METHODS FOR CONDUCTING REMOTE NEURO-OPHTHALMIC EXAMINATIONS ON A MOBILE DEVICE Thomas Jefferson University BALAJI, KAVYA SHOBANA §102§103§112 Non-Final OA — Pending Oct 03, 2024
18904642 SYSTEMS AND METHODS FOR INTERCONNECTING MANUFACTURING NODES AND CONSUMER END POINTS Global Sourcing Network LLC JEANTY, ROMAIN 3624 §101§102 Non-Final OA 62d Pending Oct 02, 2024
18900131 METHODS FOR GENERATION OF SYNTHETIC SV2A PET FROM MRI IMAGES Yale University GEBRESLASSIE, WINTA §103 Non-Final OA — Pending Sep 27, 2024
18838136 QUINAZOLINE DERIVATIVE AS KRAS G12C MUTATION INHIBITOR Shenzhen Forward Pharmaceuticals Co., Limited REILLY, SOPHIA JANE §102§103§112 Non-Final OA — Pending Sep 24, 2024
18892956 DYNAMIC WALL FOR AUGMENTED REALITY Thomas Jefferson University SANZ, GABRIEL A §103 Non-Final OA — Pending Sep 23, 2024
18844474 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING, AMELIORATING, AND/OR PRVENTING COCAINE USE DISORDER Drexel University SAMSELL, RILLA MARIE §102§103§112 Non-Final OA — Pending Sep 06, 2024
18840040 METHODS OF TREATING, AMELIORATING, OR PREVENTING HEART FAILURE, AND METHODS OF PROMOTING HEART MUSCLE GROWTH Yale University WHITE, DAWANNA SHAR-DAY §102§103§112 Non-Final OA — Pending Aug 20, 2024
18809238 MULTIDAY TIMED ENTRY TICKET SYSTEM FOR RECURRING EVENTS Runsignup, Inc. KIM, PATRICK 3628 §101§103§112 Final Rejection 252d overdue Pending Aug 19, 2024
18808807 METHOD OF RECONFIGURING A USER INTERFACE, AND SYSTEMS AND DEVICES IMPLEMENTING THE SAME Grandpad, Inc. TRAN, TAM T §103§112 Non-Final OA — Pending Aug 19, 2024
18794181 AMNIOTIC MEMBRANE POWDER AND ITS USE IN WOUND HEALING AND TISSUE ENGINEERING CONSTRUCTS Wake Forest University Health Sciences COFFA, SERGIO 1658 §103DP Non-Final OA — Pending Aug 05, 2024
18835094 PROBE FOR MONITORING RNA SPLICING AND METHODS THEREOF Yale University KOVACH, KARA NICOLE §102§103§112 Non-Final OA — Pending Aug 01, 2024
18833840 USE OF KALLIKREIN I OR DERIVATIVE THEREOF IN TREATMENT OF VCI, PSCI OR CSVD Zonhon Biopharma Institute, Inc. EPSTEIN, TODD MATTHEW §103DP Non-Final OA — Pending Jul 26, 2024
18773968 COMPOSITIONS AND METHODS FOR TREATMENT OF ACUTE LUNG INJURY The Trustees of the University of Pennsylvania LIEB, JEANETTE M §103DP Non-Final OA — Pending Jul 16, 2024
18770145 SYSTEMS AND METHODS FOR STORAGE AND EVALUATION OF SOURCE CODE The Code Registry, Inc. BERMAN, STEPHEN DAVID §101§103 Non-Final OA — Pending Jul 11, 2024
18756390 MOBILE POWER SYSTEM American Superconductor Corporation JONES, JAMES WILLIAM 3615 §103§112 Final Rejection — Pending Jun 27, 2024
18723103 SYSTEMS, DEVICES, AND METHODS FOR IMPLEMENTING COMPUTERIZED AMSLER GRID FOR EVALUATION OF VISUAL DISTURBANCES Stephane Krumenacker BROOME, SHARRIEF I 3792 §102§112 Non-Final OA — Pending Jun 21, 2024
18750780 ANTI-CAR COMPOSITIONS AND METHODS The Trustees of the University of Pennsylvania BOESEN, AGNIESZKA §102§103 Non-Final OA — Pending Jun 21, 2024
18749726 Combination Therapy for Treating or Preventing Depression or Other Mood Diseases The United States Department of Veterans Affairs LEE, CHIHYI NMN 1628 §103§112 Non-Final OA 34d Pending Jun 21, 2024
18750876 RHEOLOGICALLY MODIFIED LIQUID METAL DEVICES AND RELATED SYSTEMS AND METHODS The Regents of the University of Colorado SMOOT, MORIAH SIMONE MCMIL 3791 §102§103§112 Non-Final OA — Pending Jun 21, 2024
18720823 COMPUTER-IMPLEMENTED METHODS AND ASSOCIATED SYSTEMS FOR DETECTING MALIGNANCY The Trustees of the University of Pennsylvania JACOB, OOMMEN 3797 §112 Non-Final OA 33d Pending Jun 17, 2024
18716088 ANISAMIDE-CONTAINING LIPIDS AND COMPOSITIONS AND METHODS OF USE THEREOF The Trustees of the University of Pennsylvania SONG, JIANFENG 1613 §112 Final Rejection — Pending Jun 03, 2024
18670290 COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES The Trustees of the University of Pennsylvania LEONARD, ARTHUR S §102§103§112DP Non-Final OA — Pending May 21, 2024
18710640 UNDERGLYCOSYLATED KALLIKREIN I, AND POLYETHYLENE GLYCOL MODIFIER THEREOF AND PHARMACEUTICAL USE THEREOF Zonhon Biopharma Institute, Inc. SPANGLER, JOSEPH RANKIN 1656 §101§102§103§112 Non-Final OA — Pending May 16, 2024
18709860 A SEQUENTIAL, MULTI-MODAL, MULTI-PATIENT MECHANICAL VENTILATION SYSTEM Jomoco, Inc. RESTAINO, DANIELLE BERNADETTE §112 Non-Final OA — Pending May 14, 2024
18654097 INJECTABLE HYDROGEL COMPOSITIONS AND METHODS OF USE THEREOF Drexel University LAZARO, DOMINIC 1611 §112 Non-Final OA — Pending May 03, 2024
18706936 SYSTEMS, DEVICES, AND ASSOCIATED METHODS FOR THERAPEUTIC EUS ANCHOR Thomas Jefferson University FRITH, SEAN A 3798 §103 Non-Final OA 49d overdue Pending May 02, 2024
18705568 METHOD FOR TRACKING DISTRIBUTION OF A SHARED DIGITAL MEDIA FILE BLACKBIRD PLC SAINT CYR, JEAN D 2425 §103 Final Rejection 100d overdue Pending Apr 28, 2024
18705295 Compositions and Methods for Diagnosis and Therapy of Viral Infection George Mason Research Foundation, Inc. GILL, RACHEL B §101§102§112 Non-Final OA — Pending Apr 26, 2024

View all 165 →

Managing Saul Ewing LLP (Philadelphia)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Saul Ewing LLP (Philadelphia)'s patent allowance rate?

81.4% of resolved applications prosecuted by Saul Ewing LLP (Philadelphia) were allowed, across 5,449 applications in USPTO records.

How many office actions does Saul Ewing LLP (Philadelphia) average before allowance?

3.93 office actions per allowed application on average.

How many pending office actions does Saul Ewing LLP (Philadelphia) have?

165 pending office actions as of October 2026, for 74 clients, before 156 examiners in 83 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month